Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 5, 2012, Pages 424-430

  Shab Bidar, Sakineh ^a   Neyestani, Tirang R ^b   Djazayery, Abolghassem ^a   Eshraghian, Mohammad Reza ^a   Houshiarrad, Anahita ^b   Kalayi, Ali ^b   Shariatzadeh, Nastaran ^b   Khalaji, Niloufar ^b   Gharavi, A'azam ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Cytokines; Serum amyloid A; Systemic inflammation; Type 2 diabetes; Vitamin D

Indexed keywords

AMYLOID A PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; INSULIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; YOGHURT;

ARTICLE; BODY FAT; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CONTROLLED STUDY; FOOD INTAKE; HUMAN; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKINS; MALE; MIDDLE AGED; PROGNOSIS; SERUM AMYLOID A PROTEIN; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

EID: 84863757817     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2290     Document Type: Article

References (61)

1. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes. Diabetes 2003; 52(3): 812.
2. Pickup J, Mattock M. Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus. Diabet Med 2003; 20(9): 723-726.
3. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe G, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002; 51(5): 1596-1600.
4. Harding AH, Wareham NJ, Bingham SA, Khaw K, Luben R, Welch A, et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer--Norfolk prospective study. Arch Intern Med 2008 Jul 28; 168(14): 1493-1499.
5. Guo SW, Magnuson VL, Schiller JJ, Wang X, Wu Y, Ghosh S. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am J Epidemiol 2006 Oct 15; 164(8): 711-724.
6. Hozawa A, Jacobs DR Jr, Steffes MW, Gross MD, Steffen LM, Lee DH. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study. Clin Chem 2007; 53(3): 447.
7. Ford E, Liu S, Mannino D, Giles W, Smith S. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr 2003; 57(9): 1157-1163.
8. Neyestani TR, Hajifaraji M, Omidvar N, Eshraghian MR, Shariatzadeh N, Kalayi A, et al. High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert. Public Health Nutr 2011 Feb 28: 1-7.
9. McCarty MF. Secondary hyperparathyroidism promotes the acute phase response-a rationale for SUPPLemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 2005; 64(5): 1022-1026.
10. Holick MF. Vitamin D deficiency. N Engl J Med 2007 Jul 19; 357(3): 266-281.
11. Salekzamani S, Neyestani TR, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, et al. Is vitamin D status a determining factor for metabolic syndrome? A case-control study. Diab Metab Synd Obesity targets ther 2011; 2: 205-211.
12. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007; 56(7): 2143-2149.
13. Holick MF. The vitamin D epidemic and its health consequences. J Nutr 2005 Nov; 135(11): 2739S-2748S.
14. Hess K, Grant PJ. Inflammation and thrombosis in diabetes. Thromb Haemost 2011 May; 105(SUPPL 1): S43-S54.
15. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011 Jan; 57(1): 63-69.
16. Prospective U. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lance 1998; 352(9131): 837-853.
17. Control TD, Group CTR. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977-986.
18. Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 2009 Nov; 19(9): 604-612.
19. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009 May 23; 373(9677): 1765-1772.
20. Shab-Bidar S, Neyestani TR, Djazayery A, Houshiarrad A, Gharavi A, Kalayi A, et al. Regular consumption of vitamin D-fortified Persian yogurt drink (Doogh) may improve endothelial biomarkers in type 2 diabetes: a randomized double-blind clinical trial. BMC Med 2011; 24(9): 125.
21. Neyestani T, Gharavi A, Kalayi A. Iranian diabetics may not be vitamin D deficient more than healthy subjects. Acta Med Iran 2008; 46(4): 337-341.
22. Shab-Bidar S, Neyestani TR, Djazayery A. Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in subjects with type 2 diabetes: a study protocol for a randomized controlled clinical trial. BMC Endocr Disord 2011 Jun 22; 11(1): 12.
23. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002 Jan; 87(1): 144-147.
24. Neyestani TR, Gharavi A, Kalayi A. Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res 2007; 77(5): 341-346.
25. Neyestani TR, Gharavi A, Kalayi A. Selective effects of tea extract and its phenolic compounds on human peripheral blood mononuclear cell cytokine secretions. Int J Food Sci Nutr 2009; 60: 79-88.
26. Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr 2007 Oct; 98(SUPPL 1): S29-S35.
27. Riachy R, Vandewalle B, Kerr Conte J, Moerman E, Sacchetti P, Lukowiak B, et al. 1, 25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology 2002; 143(12): 4809.
28. Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011 Feb 10; 51: 311-336.
29. Vilarrasa N, Vendrell J, Maravall J, Elio I, Solano E, San Jose P, et al. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 2010 Oct; 38(2): 235-242.
30. Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 2011 Dec 5; 347(1-2): 106-120.
31. Xu Y, Whitmer K. C-reactive protein and cardiovascular disease in people with diabetes: high-sensitivity CRP testing can help assess risk for future cardiovascular disease events in this population. Am J Nurs 2006 Aug; 106(8): 66-72.
32. Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med 2010 Apr; 123(4): 335-341.
33. Salekzamani S, Neyestani T, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, et al. Is vitamin D status a determining factor for metabolic syndrome? A case-control study. Diabetes, Metabolic Syndrome and Obesity 2011; 4: 205-212.
34. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008 Jun 23; 168(12): 1340-1349.
35. Targher G, Bertolini L, Padovani R, Zenari L, Scala L, Cigolini M, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006 Nov; 65(5): 593-597.
36. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002 Dec; 95(12): 787-796.
37. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003 Oct; 88(10): 4623-4632.
38. Gannage-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 2003 Aug; 26(8): 748-753.
39. McClung MR, Siris E, Cummings S, Bolognese M, Ettinger M, Moffett A, et al. Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene. Menopause 2006 May-Jun; 13(3): 377-386.
40. Atteritano M, Pernice F, Mazzaferro S, Mantuano S, Frisina A, D'Anna R, et al. Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1year randomized, placebo-controlled study. Eur J Pharmacol 2008 Jul 28; 589(1-3): 22-26.
41. Barnes MS, Horigan G, Cashman KD, Hill TR, Forsythe LK, Lucey AJ, et al. Maintenance of wintertime vitamin D status with cholecalciferol SUPPLementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. J Nutr 2011 Mar; 141(3): 476-481.
42. Lippi G, Montagnana M, Targher G, Guidi GC. Relationship between serum vitamin D and inflammatory markers in the general population: comment on the article by Patel et al. Arthritis Rheum 2008; 58(3): 913-914.
43. Hypponen E, Berry D, Cortina-Borja M, Power C. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 2010; 5(5): e10801.
44. Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 2006 Jun; 3(6): e287.
45. Furlaneto CJ, Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun 2000 Feb 16; 268(2): 405-408.
46. Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun 2004 Feb 6; 314(2): 363-369.
47. Hatanaka E, Monteagudo PT, Marrocos MS, Campa A. Interaction between serum amyloid A and leukocytes - a possible role in the progression of vascular complications in diabetes. Immunol Lett 2007 Feb 15; 108(2): 160-166.
48. Song C, Shen Y, Yamen E, Hsu K, Yan W, Witting PK, et al. Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes. Atherosclerosis 2009 Feb; 202(2): 596-604.
49. Hagihara K, Nishikawa T, Matsumura A, Song J, Tanaka T, Yoshizaki K. Analysis of cytokine-driven serum amyloid A expression based on the clinical results of IL-6 blocking therapy: a new cis -acting mechanism of STAT3. Inflam Regen 2006; 26(5): 453-459.
50. Hu FB, Meigs JB, Li TY, Rifai N, Manson JAE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53(3): 693.
51. Haddy N, Sass C, Droesch S, Zaiou M, Siest G, Ponthieux A, et al. IL-6, TNF-[alpha] and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003; 170(2): 277-283.
52. Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, et al. Vitamin D SUPPLementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89(5): 1321.
53. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D SUPPLementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006; 83(4): 754.
54. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1, 25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007 Jul; 77(1): 47-57.
55. Herity NA. Interleukin 6: a message from the heart. Heart 2000 Jul; 84(1): 9-10.
56. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990 Apr; 7(2): 147-159.
57. Yusupov E, Li-Ng M, Pollack S, Yeh JK, Mikhail M, Aloia JF. Vitamin d and serum cytokines in a randomized clinical trial. Int J Endocrinol 2010; 2010.
58. Bazzoni F, Tamassia N, Rossato M, Cassatella MA. Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils. Eur J Immunol 2010 Sep; 40(9): 2360-2368.
59. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 2009 Aug; 9(4): 447-453.
60. Dupont E, Craciun L. UV-induced immunosuppressive and anti-inflammatory actions: mechanisms and clinical applications. Immunotherapy 2009 Mar; 1(2): 205-210.
61. Lee JH, Lee W, Kwon OH, Kim JH, Kwon OW, Kim KH, et al. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy. Ann Clin Lab Sci 2008 Autumn; 38(4): 361-367.